P-glycoprotein increases from proximal to distal regions of human small intestine

被引:242
作者
Mouly, S
Paine, MF [1 ]
机构
[1] Univ N Carolina, Gen Clin Res Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Div Pharmacotherapy, Chapel Hill, NC 27599 USA
[3] Hop Lariboisiere, Serv Med Inerne A, F-75475 Paris 10, France
关键词
P-glycoprotein; human; intestine; absorption; drugs;
D O I
10.1023/A:1026183200740
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The contribution of the efflux transporter P-glycoprotein (P-gp) as a barrier to drug absorption may depend on its level of expression at the site of absorption. Accordingly, the distribution of P-gp was examined along the entire length of the human small intestine. Methods. Homogenates prepared from mucosal scrapings from every other 30-cm segment of four unrelated human donor small intestines were analyzed for P-gp and the control protein villin by Western blot. Results. In each donor intestine, relative P-gp expression (P-gp/villin integrated optical density ratio) progressively increased from proximal to distal regions. Among individuals, relative P-gp levels varied 2.1-fold in the duodenal/proximal jejunal region, 1.5- to 2.0-fold in the middle/distal jejunal region, and 1.2- to 1.9-fold in the ileal region. Within-donor variation was somewhat greater, from 1.5- to 3.0-fold. Conclusions. These results provide further evidence that the site of absorption can represent another source for the interindividual variation in the oral bioavailability of drugs.
引用
收藏
页码:1595 / 1599
页数:5
相关论文
共 34 条
[1]   Role of transport proteins in drug absorption, distribution and excretion [J].
Ayrton, A ;
Morgan, P .
XENOBIOTICA, 2001, 31 (8-9) :469-497
[2]  
DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387
[3]   St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 [J].
Dürr, D ;
Stieger, B ;
Kullak-Ublick, GA ;
Rentsch, KM ;
Steinert, HC ;
Meier, PJ ;
Fattinger, K .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) :598-604
[4]   EXPRESSION OF A MULTIDRUG-RESISTANCE GENE IN HUMAN-TUMORS AND TISSUES [J].
FOJO, AT ;
UEDA, K ;
SLAMON, DJ ;
POPLACK, DG ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :265-269
[5]   Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: In vitro in vivo correlation [J].
Fricker, G ;
Drewe, J ;
Huwyler, J ;
Gutmann, H ;
Beglinger, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (07) :1841-1847
[6]   Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin [J].
Geick, A ;
Eichelbaum, M ;
Burk, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14581-14587
[7]   Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters [J].
Glaeser, H ;
Drescher, S ;
van der Kuip, H ;
Behrens, C ;
Geick, A ;
Burk, O ;
Dent, J ;
Somogyi, A ;
von Richter, O ;
Griese, EU ;
Eichelbaum, M ;
Fromm, MF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :131-140
[8]   Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans [J].
Gramatte, T ;
Oertel, R ;
Terhaag, B ;
Kirch, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (05) :541-549
[9]  
Hall Stephen D., 1999, Drug Metabolism and Disposition, V27, P161
[10]   IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES [J].
KOLARS, JC ;
SCHMIEDLINREN, P ;
SCHUETZ, JD ;
FANG, C ;
WATKINS, PB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1871-1878